(Q39915689)

15 September 2017

A Placebo Controlled Trial of Viloxazine with and without Tranquillizers in Depressive Illness (English)

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

19 December 2022

0 references

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

19 December 2022

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

19 December 2022

author name string

R. V. Magnus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A162677

19 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=162677

19 December 2022

publication date

1 January 1975

1 reference

full work available at URL

15 September 2017

http://journals.sagepub.com/doi/pdf/10.1177/030006057500300311

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

Journal of International Medical Research

19 December 2022

published in

1 reference

15 September 2017

3

1 reference

15 September 2017

207-213

1 reference

15 September 2017

3

1 reference

The clinical pharmacology of viloxazine hydrochloride-a new anti-depressant of novel chemical structure

15 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F030006057500300311

Iatrogenic epilepsy due to antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006057500300311

Some preliminary observations on ICI 58 834, a new psychotropic agent, in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006057500300311

Are Antidepressants Better Than Placebo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006057500300311

2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006057500300311

A new potential antidepressive

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

Clinical use of psychotherapeutic drugs. II. Antidepressant and antianxiety drugs and special problems in the use of psychotherapeutic drugs.

19 December 2022

5

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

An electroencephalographic study of the analeptic effects of imipramine

19 December 2022

6

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

A Clinical Trial of ICI 58,834 – A Potential Anti-Depressant

19 December 2022

10

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

A double-blind controlled study of viloxazine and imipramine in depression

19 December 2022

11

1 reference

https://api.crossref.org/works/10.1177/030006057500300311

19 December 2022

Identifiers

1 reference

15 September 2017

1 reference